1. Delivery of CRISPR-Cas systems using phage-based vectors. (April 2021) Authors: Fage, Clément; Lemire, Nicolas; Moineau, Sylvain Journal: Current opinion in biotechnology Issue: Volume 68(2021) Page Start: 174 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Molecular Pathway of Influenza Pan-neuraminidase Inhibitor Resistance in an Immunocompromised Patient. Issue 8 (November 2019) Authors: Abed, Yacine; Schibler, Manuel; Checkmahomed, Liva; Carbonneau, Julie; Venable, Marie-Christine; Fage, Clément; Giannotti, Federica; Goncalves, Ana Rita; Kaiser, Laurent; Boivin, Guy Journal: Antiviral therapy Issue: Volume 24:Issue 8(2019) Page Start: 581 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Peramivir Susceptibilities of Recombinant Influenza A and B Variants Selected with Various Neuraminidase Inhibitors. Issue 8 (November 2017) Authors: Fage, Clément; Tu, Véronique; Carbonneau, Julie; Abed, Yacine; Boivin, Guy Journal: Antiviral therapy Issue: Volume 22:Issue 8(2017) Page Start: 711 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. The combination of oseltamivir with azithromycin does not show additional benefits over oseltamivir monotherapy in mice infected with influenza A(H1N1)pdm2009 virus. Issue 12 (25th August 2017) Authors: Fage, Clément; Pizzorno, Andrés; Rhéaume, Chantal; Abed, Yacine; Boivin, Guy Journal: Journal of medical virology Issue: Volume 89:Issue 12(2017) Page Start: 2239 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗